141 related articles for article (PubMed ID: 11728072)
1. Prevention of heterotopic ossification after total hip replacement: a prospective comparison of indomethacin and salmon calcitonin in 60 patients.
Günal I; Hazer B; Seber S; Göktürk E; Turgut A; Köse N
Acta Orthop Scand; 2001 Oct; 72(5):467-9. PubMed ID: 11728072
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
Legenstein R; Bösch P; Ungersböck A
Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.
Barthel T; Baumann B; Nöth U; Eulert J
Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment.
Dorn U; Grethen C; Effenberger H; Berka H; Ramsauer T; Drekonja T
Acta Orthop Scand; 1998 Apr; 69(2):107-10. PubMed ID: 9602763
[TBL] [Abstract][Full Text] [Related]
5. The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement.
Pakos EE; Tsekeris PG; Paschos NK; Pitouli EJ; Motsis EK; Xenakis TA
J BUON; 2010; 15(1):74-8. PubMed ID: 20414931
[TBL] [Abstract][Full Text] [Related]
6. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
7. [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
Kölbl O; Flentje M; Eulert J; Barthel T; Knelles D; Kraus U
Strahlenther Onkol; 1997 Dec; 173(12):677-82. PubMed ID: 9454352
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532
[TBL] [Abstract][Full Text] [Related]
9. Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty.
van der Heide HJ; Koorevaar RT; Schreurs BW; van Kampen A; Lemmens A
J Arthroplasty; 1999 Oct; 14(7):796-9. PubMed ID: 10537252
[TBL] [Abstract][Full Text] [Related]
10. No effective prophylaxis of heterotopic ossification with short-term ibuprofen.
Koorevaar CT; Hu HP; Lemmens A; van Kampen A
Arch Orthop Trauma Surg; 1999; 119(3-4):183-5. PubMed ID: 10392515
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis for heterotopic ossification after primary total hip arthroplasty. A cohort study between indomethacin and meloxicam.
van der Heide HJ; Spruit M; Slappendel R; Klooster N; van Limbeek J
Acta Orthop Belg; 2004 Jun; 70(3):240-6. PubMed ID: 15287403
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.
Romanò CL; Duci D; Romanò D; Mazza M; Meani E
J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644
[TBL] [Abstract][Full Text] [Related]
14. Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol.
Pakos EE; Pitouli EJ; Tsekeris PG; Papathanasopoulou V; Stafilas K; Xenakis TH
Int Orthop; 2006 Apr; 30(2):79-83. PubMed ID: 16482442
[TBL] [Abstract][Full Text] [Related]
15. Short term prophylaxis against heterotopic bone after cementless hip replacement.
Wurnig C; Auersperg V; Boehler N; Steindl M; Kiss H; Zweymuller K; Kotz R
Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
[TBL] [Abstract][Full Text] [Related]
16. Low rates of heterotopic ossification after resurfacing hip arthroplasty with use of prophylactic radiotherapy in select patients.
Kruser TJ; Kozak KR; Cannon DM; Platta CS; Heiner JP; Illgen RL
J Arthroplasty; 2012 Aug; 27(7):1349-53. PubMed ID: 22245125
[TBL] [Abstract][Full Text] [Related]
17. General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty.
Hofmann S; Trnka HJ; Metzenroth H; Frank E; Ritschl P; Salzer M
Orthopedics; 1999 Feb; 22(2):207-11. PubMed ID: 10037334
[TBL] [Abstract][Full Text] [Related]
18. Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty.
D'Lima DD; Venn-Watson EJ; Tripuraneni P; Colwell CW
Orthopedics; 2001 Dec; 24(12):1139-43. PubMed ID: 11770090
[TBL] [Abstract][Full Text] [Related]
19. Naproxen in the prevention of heterotopic ossification after total hip replacement.
Vielpeau C; Joubert JM; Hulet C
Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
[TBL] [Abstract][Full Text] [Related]
20. HO prevention and the combined therapeutic protocol--do we really need it?
Kose KC; Cebesoy O; Altinel L
Int Orthop; 2007 Feb; 31(1):133-4. PubMed ID: 16900355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
